Overview

Study of ORL-1G (D-galactose) in Patients With Glycogen Storage Disease Type 14

Status:
Unknown status
Trial end date:
2019-10-31
Target enrollment:
Participant gender:
Summary
Study of ORL-1G in Patients With Glycogen Storage Disease Type 14
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Orpha Labs